As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: January 16, 2012
Translation by Maya Ehrmann for No Camel:
Findings following trials on mice and flies by researchers from Tel Aviv University, reveal that an isolated section of the cinnamon plant prevents the development of the disease and may even cure it.
Tel Aviv University researchers, headed by Professor Michael Ovadia from the Zoology Department in the Faculty of Life sciences, were able to isolate a section of the cinnamon plant capable of delaying the development of Alzheimer’s disease.
During research, the material known as CEppt was able to delay Alzheimer’s in laboratory mice bred with a gene that creates toxic amyloid molecules (plaques) which accumulate in the brain as the disease progresses. Several laboratories of the Faculty of Life Sciences were involved in the research. The findings were recently reported in the scientific journal PLoS ONE.
Alzheimer’s, which causes gradual memory loss, is a condition that can be caused by two types of brain processes identified to date: the accumulation of amyloid protein outside of the brain nerve cells and further accumulation of a protein known as tau within the nerve cells. In Israel, it is estimated that 70 thousand people suffer from Alzheimer’s and similar diseases that harm memory.
In a previous discovery, Ovadia discerned that materials in the cinnamon bark may inhibit the activity of coated viruses (e.g. influenza viruses and herpes). Researchers in the first stage of this study, conducted in laboratory test tubes, used an electronic microscope to show that the CEppt material isolated from the cinnamon was able to delay the creation of amyloid molecules. As described in the research, production of the substance entailed the creation of powder from cinnamon sticks by means of a coffee grater. The substance was isolated under laboratory conditions within a solution kept at a temperature of four degrees Celsius until ready for use.
Later, the research expanded to an examination of the material properties on mice and flies in the laboratory. These are flies bred with a gene triggering Alzheimer’s and mice bred with five genetic mutations causing aggressive development of Alzheimer’s disease by the age of two months. Animals consumed the substance in the laboratory when it was mixed in the drinking water. After four months of follow-up, researchers found that mixing cinnamon in the drinking water delayed the development of Alzheimer’s, and the documented animal behavior was similar to healthy animals of their own kind, both in terms of lifespan and in terms of activity.
A test-tube experiment also revealed that the substance helps break down amyloids that have already been created. “The finding points to the possibility that the detected material may not only prevent Alzheimer’s, but also holds healing properties after molecules which lead to Alzheimer’s have been created,” explains Ovadia. This finding necessitates further research on animals.
Ovadia became interested in the qualities cinnamon qualities already in his youth, when he claimed the title of Deputy National Youth Bible Groom, and was asked in one of the Bible trivia questions about the composition of materials in the holy ointment that priests would apply on the alter preceding a sacrifice. “I had a black out. I remembered the composition of materials, including cinnamon, just as the buzzer rang. This question bothered me and I decided to test the properties of cinnamon until I arrived at the current discovery,” says Ovadia, also an expert on snake venom research.
However, Ovadia recommends that those rushing to start using cinnamon be cautious of over-consumption. Cinnamon, in high doses, may harm the functioning of the liver, and the maximum recommended consumption of cinnamon should not exceed 10 grams per day.
Already in 2004, Tel Aviv University issued a patent on this detected material and on its function as a dietary supplement. “The discovery is very exciting because, while there are companies that develop synthetic compounds that inhibit Alzheimer’s, the discovered substance is not a drug with side effects, but rather a safe and natural substance that people consume for generations,” says Ovadia.
So far, researchers have not yet managed to isolate a single-molecule holding the healing properties out of the substance and, according to Ovadia, “Our actual attempts to separate the cinnamon materials and isolate them lead to the loss of healing qualities, as happens with many materials in nature. In the future, the research team plans to test the discovery on a new model of animals, due to the difficulty of conducting human trials on Alzheimer’s disease as the disease develops slowly. Meanwhile, Ovadia has already adopted the research findings as part of his lifestyle and has begun drinking tea daily into which he adds the active ingredient isolated from the cinnamon. According to him, “Even my students make sure to have tea with cinnamon every day. It prevents Alzheimer’s disease and viral diseases like influenza.”
Depression, stroke and dementia are twice as common in women as in men. Among Alzheimer’s patients, 70 per cent are female. But according to Lynn Posluns, the driving force behind the first “Women’s Brain...
Women are twice as likely as men to develop dementia and almost 70 per cent of new Alzheimer’s patients will be women, yet research has traditionally focused on men. Women’s Brain Health Initiative (WBHI) wants...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.